Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Comparison of administration of two standard intravenous amino acid formulas to severely brain-injured patients

  • L. G. Ott
  • , J. J. Schmidt
  • , A. B. Young
  • , D. L. Twyman
  • , R. P. Rapp
  • , P. A. Tibbs
  • , R. J. Dempsey
  • , C. J. McClain

Producción científica: Articlerevisión exhaustiva

22 Citas (Scopus)

Resumen

Twenty severely brain-injured patients with Glasgow Coma Scale scores of 4-9 were prospectively randomized to receive one of two standard amino acid formulas, starting with the first day of hospital admission up to day 14 postinjury. Formula 2 (patient group 2) had 54 percent more leucine, 53 percent more isoleucine, 74 percent more valine, 28 percent less phenylalanine, 31 percent less methionine, 111 percent more proline, 38 percent less alanine, and 38 percent less glycine than formula 1 (patient group 1). Groups 1 and 2 received statistically equal overall mean parenteral nutrition calories and protein (2173 ± 147 vs. 2059 ± 143 kcal, and 77 ± 12 vs. 83.1 ± 6 g, respectively). There was a significant difference in overall mean urinary urea nitrogen excretion (group 1 = 24.6 ± 1.3 vs. group 2 = 18.3 ± 1.1, p = 0.02) and nitrogen balance (group 1 = -8.0 ± 2.1 vs. group 2 = +1.8 ± 1.2, p = 0.01). Mean overall isoleucine values were significantly higher in group 2 (overall mean 77 μmol/L vs. 62 μmol/L, p = 0.04). Phenylalanine levels were significantly higher in group 1 (107 μmol/L) versus group 2 (82 μmol/L) patients (p = 0.01). Arginine levels were significantly higher in group 1 (78 μmol/L) versus group 2 (49 μmol/L) patients (P = 0.0002). This observation suggests that some standard intravenous amino acid formulas may be more apt to promote positive nitrogen balance than others.

Idioma originalEnglish
Páginas (desde-hasta)763-768
Número de páginas6
PublicaciónDrug Intelligence and Clinical Pharmacy
Volumen22
N.º10
DOI
EstadoPublished - 1988

Financiación

FinanciadoresNúmero del financiador
National Institute of Neurological Disorders and StrokeR01NS022712

    ASJC Scopus subject areas

    • General Pharmacology, Toxicology and Pharmaceutics
    • Pharmacology (medical)

    Huella

    Profundice en los temas de investigación de 'Comparison of administration of two standard intravenous amino acid formulas to severely brain-injured patients'. En conjunto forman una huella única.

    Citar esto